Literature DB >> 12974443

Ayurvedic pharmacoepidemiology: a proposed new discipline.

Rama A Vaidya, A D B Vaidya, B Patwardhan, G Tillu, Y Rao.   

Abstract

Mesh：

Year:  2003        PMID： 12974443

Source DB:  PubMed          Journal:  J Assoc Physicians India        ISSN： 0004-5772


× No keyword cloud information.
  9 in total

Review 1.  Ayurpharmacoepidemiology en Route to Safeguarding Safety and Efficacy of Ayurvedic Drugs in Global Outlook.

Authors:  Parikshit Debnath; Subhadip Banerjee; Anjan Adhikari; Pratip K Debnath
Journal:  J Evid Based Complementary Altern Med       Date:  2016-06-22

2.  An advocacy for Vaidya-Scientists in Ayurvedic research.

Authors:  Ashok D B Vaidya
Journal:  J Ayurveda Integr Med       Date:  2010-01

3.  Ayurveda GCP Guidelines: Need for freedom from RCT ascendancy in favor of whole system approach.

Authors:  Bhushan Patwardhan
Journal:  J Ayurveda Integr Med       Date:  2011-01

4.  "Science means learning to say-I don't know": An interview with Dr. Ashok D.B. Vaidya.

Authors:  Ravindra R Pandharinath
Journal:  J Ayurveda Integr Med       Date:  2011-10

5.  Observational therapeutics: Scope, challenges, and organization.

Authors:  Rama Vaidya
Journal:  J Ayurveda Integr Med       Date:  2011-10

6.  Ayurveda and traditional Chinese medicine: a comparative overview.

Authors:  Bhushan Patwardhan; Dnyaneshwar Warude; P Pushpangadan; Narendra Bhatt
Journal:  Evid Based Complement Alternat Med       Date:  2005-10-27       Impact factor: 2.629

7.  Foundational principles of classical Ayurveda research.

Authors:  Somik Raha
Journal:  J Ayurveda Integr Med       Date:  2013-10

8.  Adequacy of evidence available to support the claims of efficacy of Ayurvedic medicines and treatments.

Authors:  P Ram Manohar
Journal:  Anc Sci Life       Date:  2014 Apr-Jun

9.  Wound healing activity of topical application forms based on ayurveda.

Authors:  Hema Sharma Datta; Shankar Kumar Mitra; Bhushan Patwardhan
Journal:  Evid Based Complement Alternat Med       Date:  2011-05-26       Impact factor: 2.629
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.